Stopping Trials Early Due to Harm.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 38319224.
- Also identified by DOI 10.1056/EVIDctw2100026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Stopping Trials Early Due to HarmDSMBs protect clinical trial participants from harm. We describe two trials stopped for potential harm to enrollees: a DSMB recommended termination soon after enrollment began when data showed higher mortality in the experimental versus the control arm, and a trial with completed enrollment was stopped while participants were being followed and treated.
Medical subject headings
- Early Termination of Clinical Trials